On ECHEMI
Home > Drugs > Ruili WAN DING MIN XIN Pharmaceutical Co., Ltd.
Ruili WAN DING MIN XIN Pharmaceutical Co., Ltd.
  • Founded in:

    1995-05-10
  • Country:

    China China
  • Address:

    Guofang Street, Wanding Town, Ruili City, Dehong Prefecture, Yunnan Province
  • Tax NO.:

    915331027873940654
  • Registered Funds:

    2 million yuan
  • Email:

Related Drugs
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body; plays a decisive role in osmotic pressure

More

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body; plays a decisive role in osmotic pressure

0.85% 7647-14-5 43
Potassium chloride

Supplement potassium ions and participate in maintaining body fluid volume and electrolyte balance

More

Supplement potassium ions and participate in maintaining body fluid volume and electrolyte balance

0.03% 7447-40-7 38
Calcium chloride

Supplement calcium ions and participate in maintaining body fluid volume and electrolyte balance

More

Supplement calcium ions and participate in maintaining body fluid volume and electrolyte balance

0.033% 10043-52-4 27
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body, and plays a decisive role in osmotic pressure

More

Maintains normal blood and extracellular fluid volume and osmotic pressure in the human body, and plays a decisive role in osmotic pressure

0.85% 7647-14-5 43
Potassium chloride

Supplement a small amount of potassium ions to participate in maintaining body fluid volume and electrolyte balance

More

Supplement a small amount of potassium ions to participate in maintaining body fluid volume and electrolyte balance

0.03% 7447-40-7 38
Calcium chloride

Supplement a small amount of calcium ions to participate in maintaining body fluid volume and electrolyte balance

More

Supplement a small amount of calcium ions to participate in maintaining body fluid volume and electrolyte balance

0.033% 10043-52-4 27
Norfloxacin and Glucose Injection
The main ingredients are norfloxacin and glucose
Name Description Content CAS NO. Registered Holders
Norfloxacin

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

70458-96-7 35
GLUCOSE

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

58367-01-4 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.